<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Trypan blue: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Trypan blue: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Trypan blue: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="11454" href="/d/html/11454.html" rel="external">see "Trypan blue: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F232281"><span class="drugH1">Brand Names: US</span>
<ul>
<li>MembraneBlue [DSC];</li>
<li>VisionBlue</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52868538"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Vision Blue</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F232291"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Ophthalmic Agent</li></ul></div>
<div class="block doa drugH1Div" id="F232282"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c1b81c80-2c47-4c03-aa09-bd3e1e8e2e32">Surgical aid</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Surgical aid:</b> Ophthalmic:</p>
<p style="text-indent:-2em;margin-left:4em;">Cataract surgery: 0.06% solution (VisionBlue): Apply onto anterior lens capsule using a blunt cannula.</p>
<p style="text-indent:-2em;margin-left:4em;">Vitrectomy surgery: 0.15% solution (MembraneBlue): Apply to epiretinal membranes using a blunt cannula after fluid-air exchange <b>or</b> inject directly in a balanced salt solution-filled vitreous cavity.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990221"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50987521"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F232283"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F232287"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c1b81c80-2c47-4c03-aa09-bd3e1e8e2e32">Surgical aid</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Surgical aid: </b> Children and Adolescents: Ophthalmic: Topical: Refer to adult dosing.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51193059"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block dohp drugH1Div" id="F51193060"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block adr drugH1Div" id="F232269"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined: Ophthalmic: Ocular discoloration (inadvertent staining of posterior lens and vitreous face; staining may last up to 1 week)</p></div>
<div class="block coi drugH1Div" id="F232277"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Use when a nonhydrated (dry state), hydrophilic acrylic intraocular lens (IOL) insertion is planned (potential for the dye to be absorbed by and stain the IOL) </p></div>
<div class="block war drugH1Div" id="F232267"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Administration: MembraneBlue: Prime the syringe by retracting plunger or twist plunger with a clockwise motion before injection; ensure the syringe plunger moves smoothly prior to use.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Appropriate use: Remove excess dye after use to prevent excessive staining.</p></div>
<div class="block foc drugH1Div" id="F232273"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution Prefilled Syringe, Intraocular: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">MembraneBlue: 0.15% (0.5 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">VisionBlue: 0.06% (0.5 mL)</p></div>
<div class="block geq drugH1Div" id="F232265"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block fee drugH1Div" id="F16324045"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution Prefilled Syringe</b> (VisionBlue Intraocular)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.06% (per 0.5 mL): $91.56</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52868539"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution Prefilled Syringe, Intraocular: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Vision Blue: 0.06% (0.5 mL)</p></div>
<div class="block adm drugH1Div" id="F232275"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Ophthalmic: Topical:</p>
<p style="text-indent:-2em;margin-left:2em;">0.06% solution (VisionBlue): To minimize dilution of the dye (trypan blue) by the aqueous, an air bubble should be injected into the anterior chamber of the eye after opening the eye, but prior to application of trypan blue. Irrigate with balanced salt solution to remove excess dye.</p>
<p style="text-indent:-2em;margin-left:2em;">0.15% solution (MembraneBlue): Ensure that the plunger moves smoothly before use. Prime the syringe prior to injecting the fluid. Alternatively, twist the plunger into the stopper in a clockwise motion until tight. Once tight, continue turning the plunger in a clockwise motion until the stopper rotates freely in the syringe (2 or 3 rotations). If applying to epiretinal membranes, must perform a fluid-air exchange prior to injection of trypan blue to prevent aqueous dilution of the dye; immediately remove all excess dye following injection. If injecting directly into a balanced salt solution filled-vitreous cavity, wait 30 seconds following injection (sufficient staining is achieved after 30 seconds), then remove all excess dye.</p></div>
<div class="block admp drugH1Div" id="F52613986"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Ophthalmic: Topical:</p>
<p style="text-indent:-2em;margin-left:2em;">Trypan blue 0.06% (VisionBlue): To minimize dilution of the dye (trypan blue) by the aqueous, an air bubble should be injected into the anterior chamber of the eye after opening the eye, but prior to application of trypan blue. Irrigate with balanced salt solution to remove excess dye.</p>
<p style="text-indent:-2em;margin-left:2em;">Trypan blue 0.15% (MembraneBlue): Ensure that the plunger moves smoothly before use. Prime the syringe prior to injecting the fluid. Alternatively, twist the plunger into the stopper in a clockwise motion until tight. Once tight, continue turning the plunger in a clockwise motion until the stopper rotates freely in the syringe (two or three rotations). If applying to epiretinal membranes, must perform a fluid-air exchange prior to injection of trypan blue to prevent aqueous dilution of the dye; immediately remove all excess dye following injection. If injecting directly into a balanced salt solution filled-vitreous cavity, wait 30 seconds following injection (sufficient staining is achieved after 30 seconds), then remove all excess dye.</p></div>
<div class="block use drugH1Div" id="F232274"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Surgical aid (ophthalmic):</b></p>
<p style="text-indent:-2em;margin-left:4em;">0.06% solution (VisionBlue): Stains the anterior capsule of the lens in cataract surgery.</p>
<p style="text-indent:-2em;margin-left:4em;">0.15% solution (MembraneBlue): Stains the epiretinal membranes, facilitating removal of the tissue during vitrectomy procedures.</p></div>
<div class="block mst drugH1Div" id="F27999692"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">VisionBlue may be confused with methylene blue </p></div>
</div>
</div>
<div class="block pri drugH1Div" id="F232278"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Adverse events were observed in animal reproduction studies.</p>
<p style="text-indent:0em;margin-top:2em;">Systemic exposure is negligible following ophthalmic use as recommended.</p></div>
<div class="block brc drugH1Div" id="F17969771"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">It is not known if trypan blue is present in breast milk.</p>
<p style="text-indent:-2em;margin-left:2em;">Systemic exposure is negligible following ophthalmic use as recommended.</p></div>
<div class="block pha drugH1Div" id="F232266"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">An acid di-azo group dye that selectively stains connective tissue structures and epiretinal membranes in the human eye, facilitating visualization during ophthalmic surgery.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58199185"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Contrast blue</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Bluring | Tryblue</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-16581432">
<a name="16581432"></a>Jacobs DS, Cox TA, Wagoner MD, et al. Capsule staining as an adjunct to cataract surgery: a report from the American Academy of Ophthalmology. <i>Ophthalmol</i>. 2006; 113(4):707-713.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/trypan-blue-drug-information/abstract-text/16581432/pubmed" id="16581432" target="_blank">16581432</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  MembraneBlue (trypan blue) [prescribing information]. Exeter, NH: Dutch Ophthalmic USA; August 2014.</div>
</li>
<li>
<div class="reference">
                  VisionBlue (trypan blue) [prescribing information]. Exeter, NH: Dutch Ophthalmic USA; December 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19682624">
<a name="19682624"></a>Rodrigues EB, Costa EF, Penha FM, et al. The use of vital dyes in ocular surgery. <i>Surv Ophthalmol</i>. 2009; 54(5):576-617.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/trypan-blue-drug-information/abstract-text/19682624/pubmed" id="19682624" target="_blank">19682624</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 10331 Version 120.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
